USE OF RECOMBINANT ERYTHROPOIETIN FOR THE MANAGEMENT OF SEVERE HEMOLYTIC DISEASE OF THE NEWBORN OF A K0 PHENOTYPE MOTHER

Author: Manoura Antonia   Korakaki Eftychia   Hatzidaki Eleftheria   Saitakis Emmanuel   Maraka Sofia   Papamastoraki Isabella   Matalliotakis Emmanuel   Foundouli Kaliopi   Giannakopoulou Christine  

Publisher: Informa Healthcare

ISSN: 1521-0669

Source: Pediatric Hematology and Oncology, Vol.24, Iss.1, 2007-01, pp. : 69-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract